Barotrauma in Adults With Critical COVID-19

NCT05877443 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 669

Last updated 2023-05-30

No results posted yet for this study

Summary

During the pandemic of COVID-19, studies reporting a high incidence of barotrauma, both pneumothorax but also pneumomediastinum, in patients with critical COVID-19. If this is complications of the respiratory support used to treat patients hypoxemia or if it is a direct consequence of COVID-19 damaging the lung tissue is not known.

The aim of this study is to investigate the incidence and type barotrauma, if there is an association between barotrauma and level of respiratory support used in the intensive care unit, and if barotrauma is associated with worse outcome compared to patients without barotrauma.

Conditions

Interventions

PROCEDURE

Open system

Oxygen delivered on open system, for example high flow nasal cannula or low flow oxygen by nasal cannula or face mask

PROCEDURE

Non-invasive mechanical ventilation

Respiratory support by for example continues or bilevel positive airway pressure

PROCEDURE

Invasive mechanical ventilation

Respiratory support delivered through endotracheal tube or tracheostomy

Sponsors & Collaborators

Principal Investigators

  • Sandra Jonmarker, Ph D · Stockholm South General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2021-05-31
Completion
2021-08-29

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05877443 on ClinicalTrials.gov